Full-Time
IT Infrastructure Solution Architect
d/f/m
Ottobock
1,001-5,000 employees
Global prosthetics, orthotics, and mobility devices
No salary listed
Germany + 1 more
More locations: Berlin, Germany
In Person
 DevOps & Infrastructure (1) |
|---|
 Sales & Solution Engineering (1) |
|---|
Get referred to Ottobock
See people who can refer or advise you
- Several years of experience (approx. 3+ years) in IT infrastructure, architecture, or a comparable role
- Broad technical understanding with the ability to identify and assess dependencies across different services
- Experience working in complex IT environments, ideally within international and multi-provider setup
- Ability to dive into technical details while maintaining a strategic, cross-functional perspective to steer and prioritize initiatives
- Strong communication and influencing skills, with the ability to align diverse stakeholders around common solutions
- Structured and pragmatic way of working with a focus on delivering practical results
- Fluent German and English language skills
- Design and develop infrastructure solutions across multiple services with a strong focus on efficiency, stability, and cost optimization
- Support Service Owners in further developing their services within the context of the overall IT landscape
- Act as the key interface between Infrastructure, Application/Development Teams, and Enterprise Architecture
- Collaborate closely with our service providers on technical designs in a hands-on manner while bringing structure to decision-making processes
- Ensure that changes improve the overall user experience rather than optimizing individual services in isolation
- Drive standardization and stronger integration within a global multi-provider environment
- You will work across multiple domains, including: Workplace, Global Service Desk, Smart Network & Connectivity, Hybrid Cloud, Identity & Access Management (IAM) and Security
Ottobock designs and sells prosthetics, orthotics, wheelchairs, and exoskeletons to help people with mobility impairments move more independently. Its microprocessor-controlled prosthetics use sensors and actuators to adapt to gait and improve balance, while ergonomic exoskeletons support movement for users with limited strength. Its family-owned heritage since 1919, global reach in about 60 countries, and partnerships like the Paralympic Games set it apart through a focus on quality and social responsibility. Its goal is to improve mobility and independence by delivering reliable assistive technologies and supporting inclusion in daily life and sport.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Duderstadt, Germany
Founded
1919
Get referred to Ottobock
See people who can refer or advise you
Simplify's Take
What believers are saying
- H1 2026 core revenue rose 7.7% to €818.5 million, with EBITDA margin at 25.3%.
- Ottobock narrowed 2026 guidance on August 13, 2026, signaling stronger demand and operating leverage.
- The July 2026 Fesia deal and Blue Arbor investment deepen the neuro-orthotics pipeline immediately.
What critics are saying
- Grizzly Research’s May 2026 report triggered legal threats and BaFin scrutiny over Russia allegations.
- The June 2026 Human Mobility sale shrinks revenue breadth and risks execution slippage before H2 2026.
- Hans Georg Näder’s control keeps governance and reputational risk concentrated; an adverse probe can crush the IPO.
What makes Ottobock unique
- Ottobock dominates prosthetics and neuro-orthotics, pairing devices with clinics across nearly 60 countries.
- Its FES and exoskeleton platforms combine hardware, software, and patient-care services into sticky workflows.
- Blue Arbor and Fesia extend Ottobock into implanted control and functional electrical stimulation.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Holidays
401(k) Company Match
100% company-paid short & long-term disability
Company News
Ottobock has released the #DearAI Community Library, one of the first open-source image datasets depicting people with limb loss and limb differences in everyday life. The library, powered by Microsoft and now available on Hugging Face, was created and annotated by the community itself to address AI's lack of disability representation. Research across 444 AI-generated images found not a single person with visible disability appeared in 37 occupations. When disability does appear, nearly 100% default to wheelchair depictions, making prosthetic users effectively invisible. An international group of Ottobock prosthetic users worked within Microsoft's Community Library Creator to select and annotate images against community-defined standards. The result includes two datasets covering upper and lower limb differences, showing people as parents, colleagues, athletes and community members. The library is freely accessible to researchers, developers, brands and creators at huggingface.co/ottobock.
German MedTech company Ottobock is acquiring Spanish firm Fesia Technology to expand its neuro-orthotics portfolio. The deal, expected to close in approximately six months, will add functional electrical stimulation (FES) technology to Ottobock's product range. Financial terms were not disclosed. Fesia, based in Donostia/San Sebastián, employs around 20 people and develops FES systems for patients with neurological conditions including stroke, multiple sclerosis, cerebral palsy, and spinal cord injuries. The technology uses electrical impulses to stimulate weakened muscles and support the formation of new neural connections. Ottobock CEO Oliver Jakobi said neurological conditions are a major focus for the orthotics and prosthetics industry, with the number of affected people steadily increasing worldwide. The acquisition strengthens Ottobock's position as a global leader in neuro-orthotics whilst providing access to an innovative FES technology platform.
Ottobock SE KGaA reported solid earnings supported by strong cash flow conversion. The company generated €237 million in free cash flow over the past twelve months, significantly exceeding its statutory profit of €91.8 million. The company's accrual ratio of -0.11 for the year to March 2026 indicates its free cash flow substantially surpassed reported earnings, which analysts consider a positive sign. However, unusual items worth €30 million reduced Ottobock's profit during the period. These one-time expenses contributed to the strong cash conversion metrics but are not expected to recur. Analysts suggest that without these unusual charges, Ottobock should deliver higher profits in the coming year, assuming other factors remain constant.
Blue Arbor Technologies has secured a $5 million investment from Ottobock, the global prosthetics leader, to advance its RESTORE Neuromuscular Interface System. Ottobock will lead Blue Arbor's Series A financing and hold a board seat. The FDA breakthrough-designated RESTORE System provides a fully implanted neuromuscular interface connecting advanced prostheses directly to patients' residual muscles and peripheral nerves. It enables independent, simultaneous control of fingers, wrist and elbow, with trials demonstrating stable signal capture for over five years. In December 2025, surgeons at the Medical University of Vienna completed the first-in-human RESTORE procedure. Within days, the patient demonstrated functional use with an Ottobock prosthetic. Founded by Drs Paul Cederna, Theodore Kung and Alex Vaskov, Blue Arbor has been awarded over $60 million in research grants and published more than 200 peer-reviewed papers.
Blue Arbor Technologies announces $5 million investment by Ottobock to advance RESTORE™ System, designed to enable intuitive prosthetic control